Literature DB >> 17266900

[Use of complementary and alternative medicine and drug abuse in patients with inflammatory bowel disease].

Esther García-Planella1, Laura Marín, Eugeni Domènech, Isabel Bernal, Míriam Mañosa, Yamile Zabana, Miquel A Gassull.   

Abstract

BACKGROUND AND
OBJECTIVE: The use of complementary and alternative medicine (CAM) is increasing in last years. Studies performed out of Spain have reported rates of CAM use of 40-50% among IBD patients. There are no available data on drug abuse among IBD patients. The aims of our study were to evaluate the rate and associate factors of CAM use and drug abuse among Spanish IBD patients. PATIENTS AND
METHOD: Anonymous, structured questionnaire, administered to consecutive patients with IBD of at least 2 years of duration, seen in a IBD outpatient clinic.
RESULTS: Twenty-six per cent of the 214 included patients reported having used CAM. No associated factors were found, although patients with ulcerative colitis tended to a higher rate of CAM use. Ten per cent of patients admitted to consume drugs, mainly cannabis derivatives. Younger age and college and universitary degree were the only factors associated to cannabis consumption.
CONCLUSIONS: The rate of CAM use in IBD patients from a Spanish referral centre is lower than those described in other countries. About 10% of IBD patients consume cannabis, but only one third of them inform their physician about it.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17266900     DOI: 10.1157/13097468

Source DB:  PubMed          Journal:  Med Clin (Barc)        ISSN: 0025-7753            Impact factor:   1.725


  10 in total

1.  The effects of Delta-tetrahydrocannabinol and cannabidiol alone and in combination on damage, inflammation and in vitro motility disturbances in rat colitis.

Authors:  J M Jamontt; A Molleman; R G Pertwee; M E Parsons
Journal:  Br J Pharmacol       Date:  2010-06       Impact factor: 8.739

2.  Is Cannabis of Potential Value as a Therapeutic for Inflammatory Bowel Disease?

Authors:  Timna Naftali
Journal:  Dig Dis Sci       Date:  2019-10       Impact factor: 3.199

3.  Therapeutic Use of Cannabis in Inflammatory Bowel Disease.

Authors:  Waseem Ahmed; Seymour Katz
Journal:  Gastroenterol Hepatol (N Y)       Date:  2016-11

Review 4.  Cannabis and Cannabis Derivatives for Abdominal Pain Management in Inflammatory Bowel Disease.

Authors:  Kaleb Bogale; Wesley Raup-Konsavage; Shannon Dalessio; Kent Vrana; Matthew D Coates
Journal:  Med Cannabis Cannabinoids       Date:  2021-06-21

5.  Development of a plant-produced recombinant monoclonal antibody against Δ-9-tetrahydrocannabinol (Δ9-THC) for immunoassay application.

Authors:  Wanuttha Boonyayothin; Khwanlada Kobtrakul; Petlada Khositanon; Sornkanok Vimolmangkang; Waranyoo Phoolcharoen
Journal:  Biotechnol Rep (Amst)       Date:  2022-03-26

Review 6.  The Role of Cannabis in the Management of Inflammatory Bowel Disease: A Review of Clinical, Scientific, and Regulatory Information.

Authors:  Arun Swaminath; Eric P Berlin; Adam Cheifetz; Ed Hoffenberg; Jami Kinnucan; Laura Wingate; Sarah Buchanan; Nada Zmeter; David T Rubin
Journal:  Inflamm Bowel Dis       Date:  2019-02-21       Impact factor: 5.325

7.  Sexual function and patients' perceptions in inflammatory bowel disease: a case-control survey.

Authors:  Laura Marín; Míriam Mañosa; Esther Garcia-Planella; Jordi Gordillo; Yamile Zabana; Eduard Cabré; Eugeni Domènech
Journal:  J Gastroenterol       Date:  2012-11-03       Impact factor: 7.527

Review 8.  Cannabis, Cannabinoids, and the Endocannabinoid System-Is there Therapeutic Potential for Inflammatory Bowel Disease?

Authors:  Tim Ambrose; Alison Simmons
Journal:  J Crohns Colitis       Date:  2019-03-30       Impact factor: 9.071

9.  Acute and short-term administrations of delta-9-tetrahydrocannabinol modulate major gut metabolomic regulatory pathways in C57BL/6 mice.

Authors:  Megha Oza; William Becker; Phani M Gummadidala; Travis Dias; Mayomi H Omebeyinje; Li Chen; Chandrani Mitra; Rubaiya Jesmin; Paramita Chakraborty; Mathew Sajish; Lorne J Hofseth; Koyeli Banerjee; Qian Wang; Peter D R Moeller; Mitzi Nagarkatti; Prakash Nagarkatti; Anindya Chanda
Journal:  Sci Rep       Date:  2019-07-19       Impact factor: 4.379

10.  Effect of Taijiquan assisted rehabilitation for breast cancer patients: A protocol for systematic review and meta-analysis.

Authors:  Sihua Zhao; Rongna Lian; Ruinian Zhang; Fanghong Wang; Hao Chen; Run Wan
Journal:  Medicine (Baltimore)       Date:  2021-04-02       Impact factor: 1.817

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.